Get the Stockscreener App
1.89
7.39%
0.13
After Hours:
1.92
0.03
+1.59%
Pepgen Inc stock is traded at $1.89, with a volume of 802.41K.
It is up +7.39% in the last 24 hours and up +34.04% over the past month.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed that their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle, and the central nervous system. Its pipeline products are: PGN-EDO51, PGN-EDODM1, and others.
See More
Previous Close:
$1.76
Open:
$1.78
24h Volume:
802.41K
Relative Volume:
0.61
Market Cap:
$130.73M
Revenue:
-
Net Income/Loss:
$-77.22M
P/E Ratio:
-1.078
EPS:
-1.7533
Net Cash Flow:
$-77.27M
1W Performance:
+6.18%
1M Performance:
+34.04%
6M Performance:
-72.37%
1Y Performance:
+54.92%
1-Day Range:
$1.77
$1.91
1-Week Range:
$1.75
$1.91
52-Week Range:
$1.01
$7.80
Pepgen Inc Stock (PEPG) Company Profile
Name
Pepgen Inc
Sector
Industry
Phone
703-456-8000
Address
1 MARINA PARK DRIVE, SUITE 900, BOSTON
Compare PEPG vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PEPG
Pepgen Inc
|
1.89 | 124.50M | 0 | -77.22M | -77.27M | -1.7533 |
VRTX
Vertex Pharmaceuticals Inc
|
529.59 | 126.07B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
649.81 | 65.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
916.80 | 57.70B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
313.04 | 40.19B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
189.99 | 39.82B | 742.00K | -1.37B | -1.07B | -7.0731 |
Pepgen Inc Stock (PEPG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-09-25 | Initiated | Guggenheim | Buy |
| Dec-16-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-31-24 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-21-22 | Initiated | H.C. Wainwright | Buy |
Pepgen Inc Stock (PEPG) Latest News
PepGen Inc. (PEPG) Investigation: Bronstein, Gewirtz & Grossman - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Is Investigating PepGen Inc. (PEPG) And Encourages Stockholders to Connect - The National Law Review
Price to sales forward of PepGen Inc. – NASDAQ:PEPG - TradingView
Price to earnings forward of PepGen Inc. – BOATS:PEPG - TradingView
Enterprise value to EBITDA forward of PepGen Inc. – BOATS:PEPG - TradingView
Enterprise value to EBIT forward of PepGen Inc. – NASDAQ:PEPG - TradingView
Class Action Lawsuit Filed: PepGen Inc. (PEPG)Join by August 8, 2025Contact Levi & Korsinsky - The National Law Review
PEPG Stockholders Have Opportunity to Lead PepGen Inc. Class Acti - The National Law Review
PEPG INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
PEPG SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
Did You Lose Money on PepGen Inc. (PEPG)? Levi & Korsinsky Urges Investors to Act Before August 8, 2025 - The National Law Review
Why PEPG, SGMO, PHR Are Among Top Premarket Losers Today - Stocktwits
Number of shareholders of PepGen Inc. – NASDAQ:PEPG - TradingView
Price to sales forward of PepGen Inc. – BOATS:PEPG - TradingView
PepGen Inc. Actuals & Estimates (NASDAQ:PEPG) - TradingView
PEPG Forecast — Price Target — Prediction for 2027 - TradingView
PepGen (PEPG) upgraded to buy: Here's what you should know - MSN
PepGen Inc. 8-K Filing: Annual Meeting Results, Nasdaq Listing, and Key Company Information for June 2026 - Minichart
PepGen (PEPG) loses 14.3% in 4 weeks, here's why a trend reversal may be around the corner - MSN
PepGen Shareholders Back Directors and KPMG at 2026 Meeting - TipRanks
PepGen (PEPG) director granted 34,000 options for RA Capital funds - Stock Titan
Form 4 PepGen Ltd For: 22 June By Investing.com - Investing.com South Africa
34K PepGen (PEPG) options awarded for RA Capital-managed accounts - Stock Titan
PepGen (PEPG) investors elect Class I directors and ratify KPMG as 2026 auditor - Stock Titan
PepGen (PEPG) awards director 34,000 options vesting by next meeting - Stock Titan
PepGen (PEPG) director Habib Dable receives 34,000 stock options at $1.79 - Stock Titan
PepGen (PEPG) director Howard Mayer awarded options on 34,000 shares - Stock Titan
PepGen (PEPG) director receives 34,000 stock options at $1.79 strike - Stock Titan
PepGen (PEPG) director receives 34,000 stock options grant - Stock Titan
PepGen director granted options for 34,000 shares | PEPG Insider Trading - Stock Titan
PepGen joins industry leaders at BIO2026 in San Diego to advance innovation for DM1 - Traders Union
PepGen Inc (PEPG) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
PepGen Inc (PEPG) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
PepGen Inc (PEPG) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
PepGen Inc (PEPG) Valuation: PE, PB & Fair Value Analysis - TradingKey
PepGen Inc (PEPG) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
PepGen Inc (PEPG) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
PepGen Inc (PEPG) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
PepGen Inc (PEPG) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
PepGen Inc (PEPG) Institutional Confidence - TradingKey
PepGen Inc. (PEPG) Q1 2026 Earnings: Narrower Loss Beats Estimates as Clinical Programs AdvanceROA Comparison - newsline.com
PEPG Initiates Coverage On Craig-Hallum -- Rating Set to Buy - GuruFocus
Craig-Hallum initiates PepGen stock coverage with buy rating - Investing.com UK
Craig-Hallum initiates PepGen stock coverage with buy rating By Investing.com - Investing.com India
PEPG Q1 2026 Earnings: Narrower Loss Surpasses Expectations Amid Continued R&D Progress - newsline.com
PEPG Q1 2026 Earnings: Narrower-Than-Expected Loss Despite Lack of RevenueEarnings Momentum Score - lwvtexas.org
PEPG Q1 2026 Earnings: Narrower Loss Per Share Beats Estimates as Biotech Advances PipelineEarnings Surprise Stocks - newsline.com
PEPG Q1 2026 Earnings: Narrower-than-Expected Loss Drives Stock HigherEarnings Miss Alert - newsline.com
PepGen Inc. (PEPG) Q1 2026 Earnings: Narrowed Loss Surprises Analysts, Shares Edge HigherRevenue Beat Analysis - newsline.com
Pepgen Inc Stock (PEPG) Financials Data
Revenue
Net Income
Cash Flow
EPS
Pepgen Inc Stock (PEPG) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| STRECK PAUL | EVP, Head of R&D |
Mar 04 '26 |
Sale |
6.23 |
1,879 |
11,709 |
76,226 |
| Donnelly Noel | Chief Financial Officer |
Mar 04 '26 |
Sale |
6.23 |
2,084 |
12,988 |
111,603 |
| McArthur James G | President and CEO |
Mar 04 '26 |
Sale |
6.23 |
5,275 |
32,876 |
296,326 |
| Oxford Science Enterprises plc | Former 10% Owner |
Sep 30 '25 |
Buy |
3.20 |
200,000 |
640,000 |
4,955,388 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Sep 26 '25 |
Buy |
3.20 |
9,375,000 |
30,000,000 |
18,554,273 |
0.05%
0.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):